Simplify Logo

Internship

Summer 2024 – Internship

Applied Statistical Learning, Informatics & Predictive Science, Ips

Posted on 11/3/2023

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Data & Analytics
Consulting
Consumer Software
Fintech
Social Impact
Biotechnology
Healthcare

Cambridge, MA, USA

Category
AI & Machine Learning
Biology & Biotech
Data & Analytics
Required Skills
Python
R
Requirements
  • In a BS (junior/senior), MS, or PhD program in statistics, biostatistics, computational biology, machine learning, or related discipline
  • Strong statistical background, especially in non-parametric modeling and longitudinal analysis
  • Knowledge of programming languages for machine learning in R and/or python
  • Prior experience in the use of statistical learning methods such as tree-based models, regularization methods, and clustering methods
  • Ability to work independently and as a member of a broader computational team
  • Fluent verbal and written English language skills
Desired Qualifications
  • Knowledge of time-series methodologies, such as exponential smoothing and autoregressive models
  • Understanding of ensemble methods, such as bagging, boosting, and stacking
  • Prior experience with artificial neural network architectures
  • Prior experience working with clinical data

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, particularly in oncology, immunology, and cardiovascular health. The company conducts extensive research and development to create new drugs, which are then sold after receiving regulatory approval. BMS also produces generic drugs, providing affordable alternatives that maintain the same quality and safety standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while adhering to sustainability and corporate responsibility principles.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's involvement in Nobel Prize-winning immunology research underscores its leadership in groundbreaking scientific advancements.
  • The robust pipeline of molecular glues and other innovative therapies promises significant revenue growth and market expansion.
  • Recognition in the Dow Jones Sustainability Index North America highlights BMS's commitment to corporate responsibility and sustainability, enhancing its reputation and stakeholder trust.

What critics are saying

  • The termination of strategic collaborations, such as with Eisai, could impact BMS's ability to bring new therapies to market efficiently.
  • Ongoing layoffs and restructuring efforts may lead to decreased employee morale and potential disruptions in operations.

What makes Bristol-Myers Squibb unique

  • Bristol Myers Squibb's dual focus on innovative and generic medicines allows it to cater to a broad spectrum of healthcare needs, unlike competitors who may focus solely on one area.
  • Their commitment to sustainability and ESG goals sets them apart in the biopharmaceutical industry, appealing to socially conscious investors and stakeholders.
  • BMS's extensive R&D investment in oncology, immunology, and cardiovascular diseases positions it as a leader in developing cutting-edge treatments for serious diseases.
INACTIVE